Dr. Anagnostou is an Associate Professor of Oncology, Director of the Thoracic Oncology Biorepository, co-leader of the Molecular Tumor Board and co-director of the Lung Cancer Precision Medicine Center of Excellence in the Sidney Kimmel Cancer Center at Johns Hopkins. She graduated from Medical School of the National and Kapodistrian University of Athens, Greece and
received a PhD from the same institution. Dr. Anagnostou completed her internal medicine residency at Yale-New Haven Hospital and subsequently trained in Medical Oncology at Johns Hopkins. She is a translational cancer investigator who is focusing on large-scale genomic, multi-omic and liquid biopsy analyses in human cancers. Her research is particularly focused on understanding the molecular mechanisms of response and resistance to immunotherapy and translating this knowledge into minimally invasive approaches for cancer detection, monitoring and interception for patients treated with immunotherapy. Her
long term goal is to transform medical oncology to molecular oncology, where treatment decisions are tailored not only to a baseline genotype but are also informed by real-time dynamics of liquid biopsies.